ada standards of care 2025 obesity pharmacotherapy glp-1 recommendations Medical in Diabetes: Updates! Although the ADA Standards of Care is a living document throughout the 2025 Concise Clinical Guidance: An – 2025 Concise Clinical Guidance: An

This includes not only eating enough calories but also ensuring consistent intake of protein, carbohydrates, fats, fluids, and key micronutrients

There was a clear difference between groups in the Mattis cognitive assessment tests as well

Our findings may have implications for choice of glucose-lowering therapy in patients with diabetes mellitus and higher risk of dementia

GLP-1 Lawsuits: Summary of Key Information Ozempic/GLP-1 Injury Lawsuit Complaints More than a thousand individuals who have taken GLP-1 receptor agonist medications (such as Ozempic, Mounjaro, Wegovy, and Rybelsus) to treat diabetes and/or obesity have filed lawsuits seeking to recover money damages for injuries they claim to have suffered as a result of their using the diabetes and/or weight loss drugs

Conscious control has less influence over hunger than most people believe